National Health Investors (NHI) FY2020 results: revenue $333 million, up 4.6% on the year
National Health Investors Inc. (NHI) reported revenue of $333 million for fiscal 2020, the year ended 31 December 2020, up 4.6% on the year before. Net income was $185 million, up 15.4%, and diluted earnings per share $4.14. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2021.
Revenue
$333 million
+4.6% on the year
FY2013FY2020
Operating margin
n/a
50.7% a year earlier
FY2013FY2020
Net income
$185 million
+15.4% on the year
FY2013FY2020
Diluted EPS
$4.14
+12.8% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
333
318
295
+4.6%
Operating income
n/a
161
155
Operating margin
n/a
50.7%
52.6%
Interest expense
52.9
56.3
49.1
-6.1%
Pre-tax income
n/a
161
155
Income tax
n/a
n/a
0.1
Effective tax rate
n/a
n/a
0.1%
Net income
185
160
154
+15.4%
Net margin
55.6%
50.4%
52.4%
Diluted EPS
$4.14
$3.67
$3.67
+12.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
232
241
208
-3.7%
Capital expenditure
117
237
148
-50.8%
Free cash flow
115
3.8
60.2
+2,962.5%
Free cash flow margin
34.7%
1.2%
20.4%
Cash from investing
-89.7
-343
-250
Cash from financing
-112
107
44.3
Share-based compensation
5.4
3.6
2.5
+49.4%
Buybacks
0.0
n/a
n/a
Dividends paid
195
180
165
+8.3%
Dividend per share
$4.41
$4.20
$4.00
+5.0%
Diluted shares, weighted
45m
44m
42m
+2.3%
Shares outstanding at period end
45m
45m
43m
+1.3%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
1,512
1,498
1,390
+1.0%
Non-controlling interest
10.7
0.6
0.0
+1,624.8%
Debt
1,499
1,440
1,282
+4.1%
Other liabilities
98.3
104
79.2
-5.1%
Total liabilities and equity
3,120
3,042
2,751
+2.6%
Fixed assets
2,667
2,560
2,367
+4.2%
Loans
292
340
246
-14.0%
Cash and equivalents
43.3
5.2
4.7
+731.1%
Receivables
2.6
3.2
6.4
-19.2%
Other assets
115
133
127
-13.9%
Total assets
3,120
3,042
2,751
+2.6%
10-K for the year ended 31 December 2020, filed 22 February 2021: the filing.